Argen X SE Revenue Y/Y
What is the Revenue Y/Y of Argen X SE?
The Revenue Y/Y of Argen X SE is -41.40%
What is the definition of Revenue Y/Y?
Yearly revenue growth is the percentage growth of the company’s revenue over trailing twelve months.
= (revenue past four quarters - revenue previous four quarters) / revenue previous four quarters
The yearly revenue growth rate is calculated as the percentage change in revenue over the trailing twelve months. For this specific metric, the calculation takes into account a series of the last eight quarterly revenues. The revenue growth is useful for determining the success of the company expanding its main business. Revenue growth of 5% to 10% is usually considered good for large-cap companies. For other companies, a sales growth of over 10% is more desirable.
Revenue Y/Y of companies in the Health Care sector on NASDAQ compared to Argen X SE
What does Argen X SE do?
Argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer.
Companies with revenue y/y similar to Argen X SE
- TD Inc has Revenue Y/Y of -41.90%
- Cree has Revenue Y/Y of -41.85%
- Netcapital has Revenue Y/Y of -41.73%
- Netcapital has Revenue Y/Y of -41.73%
- Ultra Petroleum has Revenue Y/Y of -41.69%
- CanSino Biologics has Revenue Y/Y of -41.68%
- Argen X SE has Revenue Y/Y of -41.40%
- Tejon Ranch Co has Revenue Y/Y of -41.34%
- Educational Development has Revenue Y/Y of -41.28%
- China Futex has Revenue Y/Y of -41.23%
- Lineage Cell Therapeutics Inc has Revenue Y/Y of -41.22%
- Alliance Data Systems has Revenue Y/Y of -41.18%
- Bancroft Fund Ltd has Revenue Y/Y of -41.17%